Intrust Bank’s Emergent Biosolutions EBS Stock Holding History

Intrust Bank’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-4,342	Closed	-$404K	–	379
2021 Q1	$404K	Buy	4,342 +130	+3%	+$13.3K	0.06%	258
2020 Q4	$378K	Sell	4,212 -1	-0%	-$92	0.06%	251
2020 Q3	$436K	Sell	4,213 -399	-9%	-$43K	0.08%	202
2020 Q2	$365K	Buy	4,612 +408	+10%	+$30.4K	0.07%	233
2020 Q1	$243K	Buy	+4,204	New	+$242K	0.07%	266
2019 Q1	–	Sell	-4,762	Closed	-$283K	–	376
2018 Q4	$283K	Buy	4,762 +127	+3%	+$8.19K	0.08%	281
2018 Q3	$305K	Hold	4,635	–	–	0.08%	290
2018 Q2	$234K	Buy	+4,635	New	+$241K	0.06%	328
2016 Q3	–	Sell	-9,550	Closed	-$268K	–	338
2016 Q2	$268K	Buy	+9,550	New	+$374K	0.11%	278

Other funds holding EBS

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Intrust Bank's EBS Position: Q2 2021 in Review

Intrust Bank sold out of Emergent Biosolutions (EBS) in Q2 2021, closing a stake of 4,342 shares — an estimated $404K sold.

Intrust Bank first reported a position in EBS in Q2 2016 and held it in 9 quarters. The position peaked at $436K in Q3 2020. 290 funds tracked by Wall St. Rank hold EBS as of Q2 2021.

Intrust Bank reported no remaining Emergent Biosolutions position as of Q2 2021 after selling out during the quarter.
Intrust Bank sold 4,342 Emergent Biosolutions shares in Q2 2021, an estimated $404K.
Intrust Bank first reported a position in Emergent Biosolutions in Q2 2016 and held it in 9 quarters.
Intrust Bank's Emergent Biosolutions position peaked at $436K in Q3 2020.
290 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2021.

Based on Intrust Bank's 13F filing for Q2 2021, filed 5 Aug 2021.